Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
Overview
Affiliations
Background: The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In this study, we hypothesized that Parkinson patients with more non-motor symptoms have a different pattern of striatal dopamine depletion, particularly in areas other than the sensorimotor striatum, compared to those with fewer non-motor symptoms.
Methods: We conducted a prospective survey of the degree of non-motor symptoms (using the Korean version of the Non-Motor Symptoms Scale; K-NMSS) in 151 patients with early-stage Parkinson's disease who had undergone a dopamine transporter PET scan as an initial diagnostic procedure. We classified the patients into two groups; high non-motor patients (HNM-PD; K-NMSS score ≥ 41) and low non-motor patients (LNM-PD).
Results: Patients in the HNM-PD group (n = 71) were older, had longer symptom duration, exhibited more severe motor deficits, and had been prescribed higher levodopa-equivalent doses at follow-up than those in the LNM-PD group. However, dopamine transporter binding to the striatal sub-regions and inter-sub-regional binding ratios were comparable between the two groups. A general linear model showed that the HNM-PD group had significantly more severe motor deficits than the LNM-PD group after controlling for age, gender, symptom duration, and dopamine transporter binding to the sensorimotor striatum.
Conclusions: This study demonstrated that the pattern of striatal dopamine depletion does not contribute to early non-motor burden in Parkinson's disease. Our results suggest that LNM-PD patients may have a more benign course of motor symptom progression than HNM-PD patients.
Cortical and subcortical morphological alterations in motor subtypes of Parkinson's disease.
Li J, Zhang Y, Huang Z, Jiang Y, Ren Z, Liu D NPJ Parkinsons Dis. 2022; 8(1):167.
PMID: 36470900 PMC: 9723125. DOI: 10.1038/s41531-022-00435-3.
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.
Palermo G, Giannoni S, Bellini G, Siciliano G, Ceravolo R Int J Mol Sci. 2021; 22(20).
PMID: 34681899 PMC: 8538800. DOI: 10.3390/ijms222011234.
Emerging Concepts of Motor Reserve in Parkinson's Disease.
Chung S, Lee J, Lee P, Sohn Y J Mov Disord. 2020; 13(3):171-184.
PMID: 32854486 PMC: 7502292. DOI: 10.14802/jmd.20029.
Park S, Kwon K, Lee J, Im K, Sunwoo J, Lee K Neurol Sci. 2018; 40(2):311-317.
PMID: 30415448 DOI: 10.1007/s10072-018-3632-7.
The presence of depression in de novo Parkinson's disease reflects poor motor compensation.
Lee Y, Oh J, Chung S, Lee J, Chung S, Moon H PLoS One. 2018; 13(9):e0203303.
PMID: 30231066 PMC: 6145582. DOI: 10.1371/journal.pone.0203303.